Oxford Cancer Analytics, a fast-scaling diagnostics company, has signed for Mission Street and BGO’s Inventa, taking the building in Oxford’s West End to close to fully occupied. OXcan has committed to a new lease of 2,400 square feet and is moving from the BioEscalator to Inventa. Founded in 2019, OXcan recently completed its Series A […]
Mission Street are proud to be a signatory of the Equinox Charter, which represents a transformative opportunity to accelerate sustainable growth and attract high-value investment into Oxford’s globally recognised science and innovation sector. The built environment is an important enabler of that growth, creating world class infrastructure for companies to co-locate, attract talent and scale. We […]
Freeths chose Inventa to host their event with the Swedish Chamber of Commerce. The group, who had delegates visiting from Sweden, Finland, and Estonia, was shown what Mission Street has achieved in its redevelopment and leasing of Inventa and showcase how Oxford is a preeminent location for life science and tech companies. Nucleome Therapeutics invited […]
Very proud that Inventa won the Adaptive Reuse category at the Architect Journal awards! With the landscaping now in full bloom and the building nearing fully let – its wonderful to see the full transformation from what was once an Argos! Massive thank you to our amazing design team, led by Owers Warwick Architects who […]
PropTech Connect, a two days of an all-inclusive conference that connects leading organisations and cutting-edge solutions to increase technology adoption in Real Estate.
What Xyme, an AI-driven enzyme design company, has taken space at Inventa in Oxford Why Mission Street and BGO opened the building last year, as the first purpose-built commercial science scheme in Oxford’s West End What next Duo on site with 183,000 sq ft next phase Science and innovation developer Mission Street and investment manager BGO have signed […]
